Metraipolis › archive › dc_0763efd447d4

Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis — Europe PMC PMID:42409822

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42409822
DOI
10.1038/s41541-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-18T10:59:06.788Z
SHA-256 of the archived text
33a26701c29c9564c775a55d1427b08d3b8db4a88bd1d5e37bbc0917a669740d
Stable URL of this page
https://metraipolis.com/documento/dc_0763efd447d4

How to cite

Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis — Europe PMC PMID:42409822 — Europe PMC (en), https://europepmc.org/article/MED/42409822 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0763efd447d4 (Metraipolis archive dc_0763efd447d4, sha256 33a26701c29c9564c775a55d1427b08d3b8db4a88bd1d5e37bbc0917a669740d)
BibTeX
@misc{dc0763efd447d4,
  title = {Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis — Europe PMC PMID:42409822},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42409822},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0763efd447d4; sha256 33a26701c29c9564c775a55d1427b08d3b8db4a88bd1d5e37bbc0917a669740d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42409822. Agents can read the archived copy with the MCP tool read_document.